Additionally, in ovarian cancer models, oral mannose supplementation enriches Faecalibaculum rodentium, which suppresses tumor progression and enhances antitumor immunity by expansion of progenitor-exhausted CD8 + T cells [43]. The gene discussed is CD8A; the disease is ovarian cancer.